You are here » Home » Companies » Company Overview » Bacil Pharma Ltd

Bacil Pharma Ltd.

BSE: 524516 Sector: Health care
NSE: N.A. ISIN Code: INE711D01018
BSE LIVE 14:24 | 07 Dec 9.88 0.47
(4.99%)
OPEN

8.94

HIGH

9.88

LOW

8.94

NSE LIVE 05:30 | 01 Jan Stock Is Not Traded.
OPEN 8.94
PREVIOUS CLOSE 9.41
VOLUME 201
52-Week high 10.50
52-Week low 3.20
P/E
Mkt Cap.(Rs cr) 5.82
Buy Price 8.94
Buy Qty 70.00
Sell Price 9.88
Sell Qty 49.00
OPEN 8.94
CLOSE 9.41
VOLUME 201
52-Week high 10.50
52-Week low 3.20
P/E
Mkt Cap.(Rs cr) 5.82
Buy Price 8.94
Buy Qty 70.00
Sell Price 9.88
Sell Qty 49.00

Bacil Pharma Ltd. (BACILPHARMA) - Director Report

Company director report

To

The Members

Bacil Pharma Limited

Your directors have pleasure in presenting their 28th Annual Report on the business andoperations of the company together with the Audited Statement of Accounts for the yearended 31st March 2015.

State of Company’s Affairs and Future Outlook

The Company is in the business of Manufacturing of pharmaceuticals medicinal chemicalsand related activities. The directors framed policies and strategies for betterutilization of resources of the company. The directors are optimistic about betterfinancial result in the coming years.

The highlights of the Company’s performance are as under:

Total Income during the year was Rs. 807036/- as compared to Rs. 581822/- in theprevious year. The net loss incurred during the year was Rs. 318118/- as compared to netloss of Rs. 1090871 in the previous year. Due to recession prevailing in the market theCompany has not taken any new project and is exploring new and suitable areas of businessto diversifying its activities. In absence of any profits the Directors are notrecommending any dividend.

No activities were carried out at the plant of the Company and the expenses pertainingto the said facility were included under the head project pre-operative expenses pendingallocation as per past practice.

Capitalization of assets of the project

The Company has not yet started commercial production due to reasons beyond the controlof the management and the accounting for the total investments made by the Company in thefixed assets of the project is being relected under two relevant heads i.e. 1) CapitalWork in Progress which includes Land Building and Plant & Machinery CapitalAdvances Material at site and incidental Expenses and 2) Intangible Assets underDevelopment which includes Project Pre-operative Public Issue and Preliminary Expensespending allocations which are deferred to be adjusted till commencement of commercialproduction as explained and informed earlier reports.

The Directors have also considered to lease sale/ dispose of the Industrialundertaking (Building and Plant & Machinery) and in spite of efforts done to lease outthe assets and to sale/dispose off the same the management was unable to negotiate andfinalize any deal as the response received was not positive.

Impairment of Assets

The delay in implementation of the project and the industrial undertaking being inChemical Zone has already caused substantial depletion of the existing Plant &Machinery of the Project and will have a barring in the near future for extensive repairsand maintenance. There are indications which suggest impairment in the value of the fixedassets being Plant & Machinery and other fixed assests.

Extract of Annual Return

The extract of Annual Return in format MGT -9 for the Financial Year 2014-15 has beenenclosed with this report. Annexure I

Number of Board Meetings

During the Financial Year 2014-15 six meetings of the Board of Directors of thecompany were held. The date of the meetings of the board held is as under-

S.No. Date of Meeting Total Strength of the Board No. of Directors Present
01 30/05/2014 3 3
02 14/08/2014 3 3
03 28/08/2014 3 3
04 14/11/2014 3 3
05 14/02/2015 3 3
06 26/03/2015 3 3

Independent Directors’ Meeting

During the year under review Independent Directors met on 14th February 2015inter-alia to discuss:

Evaluation of the performance of Non-Independent Directors and the Board as whole.

Evaluation of the performance of the Chairman of the Company taking into account theviews of the Executive and Non-Executive Directors.

Evaluation of the quality quantity content and timeless of flow of information betweenthe management and the Board.

Particulars of Loan Guarantees and Investments under Section 186

Complete details of LGSI covered under Sec 186 of Companies Act 2013 as Attached inthe financial statements and notes there under.

Particulars of Contracts or Arrangements with Related Parties

All contracts / arrangements / transactions entered by the Company during the financialyear with related parties were in the ordinary course of business and on an arm’slength basis. During the year the Company had not entered into any contract / arrangement/ transaction with related parties which could be considered material in accordance withthe policy of the Company on materiality of related party transactions The Policy onmateriality of related party transactions and dealing with related party transactions asapproved by the Board.

Material Changes Affecting the Financial Position of the Company

In the Financial Year 2014 – 15 there are no Material changes which will affectthe Financial Position of the Company.

Conservation of Energy Technology Absorption Foreign Exchange Earnings and Outgo

Since the Company is not engaged in any activities the particulars relating toconservation of energy technology absorption Foreign Exchange Earnings and Outgo in theCompanies (Disclosure of Particulars in the Report of the Board of Directors) Rules 1988are not applicable.

Risk Management Policy

During the year of review company engaged in the process of Risk Management andevaluate the elements of business risk. The risk management framework defines the riskmanagement approach of the company and includes periodic review of such and alsodocumentation mitigating controls and reporting mechanism of such risk.

Details of Directors and Key Managerial Personnel

Sr. No. Name and Address Designation Date of Appointment DIN/PAN
Mr. Shirish Suryakant Shetye
603 Vastu Shilp Shree Vastu Enclave Non-executive
1 Rajmata Jijabai Marg pump house Independent 25/03/2003 00148086
Andheri east Mumbai 400093 Director
Maharashtra India
Mr. Prakash Bhoorchand Shah
2 13 Prem Niwas 652 Dr Ambedkar Director 09/08/1990
road Khar Mumbai 400052 01136800
Maharashtra India
Mr. Lalit jain Non-executive
10th a heavy industrial area jodhpur 342001 Rajasthan India Independent Director 24/02/2012 00941024
Ms. Sneha Prakash Shah Non-executive
4 13 Prem Niwas 652 dr. Ambedkar road Khar (west) Mumbai 400052 Women Director 31/03/2015 07144208
Maharashtra India Additional Director
Mr. Man Mohan Ghildyal
b-25 Sanman c-op h. society Pakhdi
5 Kharigaon kalwa (west) Thana Manager 10/06/2002 AFVPG9931N
400605 Maharashtra India
Mr. Jayesh Ramchandra Patil
23/3a Bhai Bandarkar Colony Cpt P
6 P Road Cuffe Parade Mumbai CFO 31/03/2015 ATPPP3597F
400005 Maharashtra

In accordance with the provisions of the Act and the Articles of Association of theCompany Mr. Prakash Shah Director who is liable to retire by rotation presents himselffor re-appointment.

Ms. Sneha Shah is appointed as an Additional Director (Non Executive Women Director) on31st March2015 to comply with the clause 49 of listing agreement and Provisions ofCompanies Act 2013.

The Company has received Declarations from all the Independent Directors of the Companyconfirming that they meet the criteria of independence as prescribed both under the Actand under Clause 49 of the listing agreement.

Board Evaluation

Formal Annual evaluation has been made by the Board of its own Performance and that ofits Committees & Individual Directors during the meeting of Board of Directors and bycommon discussion with concerned persons

Particulars of Employees

During the year there was no employee in receipt of remuneration as prescribed in theRule 5(2) of the companies (Appointment and Remuneration of managerial personnel) Rules2014.

Audit Committee

The Audit Committee comprises Independent Director namely Mr. Shirish S. Shetye(Chairman) Mr. Lalit Jain and Mr. Prakash B. Shah as other member. All therecommendations made by the Audit Committee were accepted by the Board.

Nomination & Remuneration Committee & Policy

The Board has framed a policy for selection and appointment of Directors SeniorManagement and their remuneration. The Details of this policy is given here under:

In compliance with section 178 of the Act and Clause 49 of the Listing Agreement theBoard has reconstituted the existing "Remuneration Committee" by changing itsNomenclature as "Nomination and Remuneration Committee".

The Nomination and Remuneration Committee comprises Non-executive Directors namely Mr.Shirish S. Shetye (Chairman) Mr. Lalit Jain and Mr. Prakash B. Shah as other member.

Stakeholders Relationship Committee

In compliance with section 178 of the Act the Board has constituted "StakeholdersRelationship Committee".

The Stakeholders Relationship Committee comprises Non-executive Directors namely Mr.Shirish S. Shetye (Chairman) Mr. Lalit Jain and Mr. Prakash B. Shah as other member.

Name of the Member Designation No. of meetings held 4
Attended
Mr. Shirish S. Shetye Chairman 4
Mr. Lalit Jain Member 4
Mr. Prakash Shah Member 4

Investor Relations

The following table shows the nature of complaints received from the Shareholdersduring the year ended 31st March 2015 all of which have been resolved during the year.

Nature of Complaints No. of Complaints
There are no complaints received from shareholders during the year
2014-2015 -

There are no Shareholders complaints pending as on 31st march 2015.

Disclosure on Establishment of a Vigil Mechanism

The Company has Vigil Mechanism/Whistle Blower Policy to deal with instance of fraudand mismanagement if any. No personnel had been denied access to the Audit Committee tolodge their grievances.

Disclosures under Sexual Harassment of Women at Workplace (Prevention Prohibition& Redressal) Act 2013

There were no complaints reported under the prevention of Sexual Harassment of Women atWorkplace (Prevention Prohibition & Redressal) Act 2013.

Fraud Reporting (Required by Companies Amendment Bill 2014)

No Fraud reported / observed during the financial year 2014 -15.

AUDITORS

Statutory Auditors

As per the rule 6 of the Companies (Audit and Auditors) Rules 2014 Company hasre-appointed Chartered Accountants M/S A.W. KETKAR & Co. (Firm Registration No:105006W) as a statutory auditor of the company for the financial year 2015-2016. Theyhave confirmed their eligibility to the effect that their re-appointment if made wouldbe within the prescribed limits under the Act and that they are not disqualified forre-appointment. The Notes on financial statement referred to in the Auditors’ Reportare self-explanatory and do not call for any further comments. The Auditors’ Reportdoes not contain any qualification reservation or adverse remark.

In this regard the Company has received a certificate from the Auditors to the effectthat if they are re-appointed it would be in accordance with the provisions of section141 of the Act.

Secretarial Audit Report

The Secretarial Audit of the Company was conducted during the year by the SecretarialAuditor M/s Amruta Kothari & Associates Practicing Company Secretaries Mumbai inaccordance with Provisions of Section 204 of the Act. The Secretarial Auditors Report isattached as Annexure II and forms part of this Report. There are Qualifications orObservations or remarks made by the Secretarial Auditor in the report.

Management reply to the observation raised in the Secretarial Audit Report is as under:

Sr No Observation Reply
1 Non compliance under section 203 of the Act with respect to the appointment of company Secretary. Considering the size and operations of the company the company is unable to find a suitable candidate for appointment as Company Secretary however the applications for the appointment have been invited by newspaper notice.
2 Delay in Appointment of Internal Auditor under section 138 of the Act There was delay due to finding the suitable professional candidate for the internal audit of the company in accordance with size and nature of the business of the company.
3 Fees for Ahmadabad and Delhi stock exchange is not paid. The Company is under process for delisting from ASE and DSE however the Ahmedabad Stock Exchange & Delhi Stock Exchange are not in operation hence no Listing fees required to be paid.

Cost Auditors

Requirements of Appointment of Cost Auditors of the company are not applicable to thecompany.

Stock Exchange

The Company’s equity shares are listed at BSE Limited ASE Limited and DSE Limitedand the Annual Listing Fees for the year 2014-2015 has been paid for BSE Limited and asother stock exchanges are non functional Listing fees are not paid.

Directors Responsibility Statement

In accordance with the provisions of Section 134(5) of the Companies Act 2013 yourdirectors confirm that:

(a) In the preparation of the annual accounts for the financial year ended 31st March2015 the applicable accounting standards had been followed along with proper explanationrelating to material departures;

(b) The directors had selected such accounting policies and applied them consistentlyand made judgments and estimates that are reasonable and prudent so as to give a true andfair view of the state of affairs of the Company as at 31st March 2015.

(c) The directors had taken proper and sufficient care for the maintenance of adequateaccounting records in accordance with the provisions of the Companies Act 2013 forsafeguarding the assets of the company and for preventing and detecting fraud and otherirregularities;

(d) The directors had prepared the annual accounts on a going concern basis;

(e) The directors had devised proper systems to ensure compliance with the provisionsof all applicable laws and that such systems were adequate and operating effectively.

Acknowledgment

The Directors express their sincere appreciation to the valued shareholders bankersprofessionals clients and devoted employees for their support.

For and on behalf of the Board of Directors
Bacil Pharma Limited
Mr. PRAKASH SHAH Mr. SHIRISH SHETYE
Place: Mumbai DIRECTOR DIRECTOR
Date: 02.09.2015 DIN–01136800 DIN–00148086

FORM NO. MR-3

SECRETARIAL AUDIT REPORT

For the Financial Year Ended 31st March 2015

[Pursuant to Section 204(1) of the Companies Act 2013 and Rule No. 9 of the Companies(Appointment and

Remuneration of Managerial Personnel) Rules 2014]

To

The Members

Bacil Pharma Limited

I have conducted the secretarial audit of the compliance of applicable statutoryprovisions and the adherence to good corporate practices by Bacil Pharma Limited (CIN:L24200MH1987PLC043427) (hereinafter called the Company). Secretarial Audit was conductedin a manner that provided us a reasonable basis for evaluating the corporateconducts/statutory compliances and expressing my opinion thereon. Based on ourverification of the books papers minute books forms and returns filed and other recordsmaintained by the Company and also the information provided by the Company its officersagents and authorized representatives during the conduct of secretarial audit we herebyreport that in our opinion the Company has during the audit period ended on 31st March2015 complied with the statutory provisions listed hereunder and also that the Companyhas proper Board-processes and compliance-mechanism in place to the extent in the mannerand subject to the reporting made hereinafter:

1. I have examined the books papers minute books forms and returns filed and otherrecords maintained by Bacil Pharma Limited ("The Company") for the period endedon 31st March 2015 according to the provisions of:

i. The Companies Act 2013 (the Act) and the Rules made thereuner; ii. The SecuritiesContracts (Regulation) Act 1956 (‘SCRA’) and the Rules made thereunder; iii.The Depositories Act 1996 and the Regulations and Bye-laws framed thereunder;

iv. Foreign Exchange Management Act 1999 and the Rules and Regulations made thereunderto the extent of Foreign Direct Investment Overseas Direct Investment and ExternalCommercial Borrowings; v. The following Regulations and Guidelines prescribed under theSecurities and Exchange Board of India Act 1992 (‘SEBI Act’) to the extentapplicable to the Company:- a. The Securities and Exchange Board of India (SubstantialAcquisition of Shares and

Takeovers)Regulations 2011; - Not Applicable to the Company During audit period b.The Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations1992; -

Not applicable to Company during Audit Period c. The Securities and Exchange Boardof India (Issue of Capital and Disclosure Requirements) Regulations 2009; - Notapplicable to Company during Audit Period d. The Securities and Exchange Board ofIndia (Registrars to an Issue and Share Transfer Agents) Regulations 1993 regarding theCompanies Act and dealing with client; - Not applicable to Company during Audit Period.e. The Securities and Exchange Board of India (Delisting of Equity Shares)Regulations 2009; - Not applicable to Company during Audit Period and f. TheSecurities and Exchange Board of India (Buyback of Securities) Regulations 1998;

- Not applicable to Company during Audit Period g. the Company has complied withthe requirements under the Equity Listing Agreements entered into with BSE LimitedNational Stock Exchange of India Limited;

- Not applicable to Company during Audit Period and h. The Memorandum andArticles of Association.

i) Secretarial Standards issued by The Institute of Company Secretaries of India.

Not notified hence not applicable to the Company during the audit period.

ii) The Listing Agreements entered into by the Company with the BSE Limited NationalStock Exchange of India Limited.

During the period under review the Company has complied with the provisions of the ActRules

Regulations Guidelines Standards Listing Agreements etc mentioned above to theextend applicable except the following:

SR. NO. APPLICABLE LAW OBSERAVTION
1 Companies Act 2013 and Delay in Appointment of Internal Auditor under section
Rules Made Thereunder 138 of the Act
Non Compliance under section 203 of The act with respect to the appointment of Company Secretary.
2 Listing Agreement Fees for Ahmadabad and Delhi stock exchange is not paid.

2. I further report that the Company has in my opinion complied with the provisionsof the Companies Act 1956 and the Rules made under that Act and the provisions ofCompanies Act 2013 as notified by Ministry of Corporate Affairs and the Memorandum andArticles of Association of the Company with regard to:

3. I further report that:

_ The Board of Directors of the Company is duly constituted with proper balance ofExecutive Directors Non-Executive Directors and Independent Directors. The changes in thecomposition of the Board of Directors that took place during the period under review werecarried out in compliance with the provisions of the Act.

_ Adequate notice is given to all directors to schedule the Board Meetings agenda anddetailed notes on agenda were sent at least seven days in advance and a system exists forseeking and obtaining further information and clarifications on the agenda items beforethe meeting and for meaningful participation at the meeting.

_ Majority decision is carried through while the dissenting members’ views arecaptured and recorded as part of the minutes.

I further report that based on the information received and records maintained thereare adequate systems and processes in the Company commensurate with the size andoperations of the Company to monitor and ensure compliance with applicable laws rulesregulations and guidelines.

I further report that there are adequate systems and processes in the companycommensurate with the size and operations of the Company to monitor and ensure compliancewith applicable laws rules regulations and guidelines.

Place : Mumbai Cs Amruta Kothari & Associates
Date : 20.08.2015 Company Secretaries
Amruta Kothari
CP. No. 9499
Membership No. 26359

ANNEXURE TO DIRECTORS REPORT

FORM NO. MGT 9

EXTRACT OF ANNUAL RETURN

As on financial year ended on 31.03.2015

Pursuant to Section 92 (3) of the Companies Act 2013 and rule 12(1) of the Company(Management & Administration) Rules 2014

I. REGISTRATION & OTHER DETAILS:

1 CIN L24200MH1987PLC043427
2 Registration Date 08/05/1987
3 Name of the Company BACIL PHARMA LTD
4 Category/Sub-category of the Company Public Company / limited by Shares
5 Address of the Registered office & contact details "71 Laxmi Building 4th Floor Sir p. m. road Fort Mumbai-400001 Maharashtra INDIA
6 Whether listed company YES
7 Name Address & contact details of the Registrar & Transfer Agent if any. Bigshare Services Pvt. Ltd E-2/3 Ansa Industrial Estate Saki Vihar Road Saki Naka Andheri (East) Mumbai-400072 Maharashtra Contact Details 022-284706524043020028470653

II. PRINCIPAL BUSINESS ACTIVITIES OF THE COMPANY (All the business activitiescontributing 10 % or more of the total turnover of the company shall be stated)

S. No. Name and Description of main products / services NIC Code of the Product/service % to total turnover of the company
1 Manufacture of pharmaceuticals medicinal chemicals and botanical product 2423 0%

III. PARTICULARS OF HOLDING SUBSIDIARY AND ASSOCIATE COMPANIES

All the business activities contributing 10 % or more of the total turnover of thecompany shall be stated:-

l. No. Name and Description of main products / services NIC Code of the Product/ service % to total turnover of the company
1 NIL - -

IV. SHARE HOLDING PATTERN (Equity Share Capital Breakup as percentage of Total Equity)Category-wise Share Holding

Category of Shareholders No. of Shares held at the beginning of the year[As on 31-March-2014] No. of Shares held at the end of the year[As on 31-March-2015]
Demat Physical Total % of Total Shares Demat Physical Total % of Total Shares % Change during the year
A. Promoter s
(1) Indian
a) Individual/ 641500 137900 779400 13.23% 773500 5900 779400 13.23% -
HUF
b) Central Govt - - - - - - - - -
c) State Govt(s) - - - - - - - - -
d) Bodies Corp. 1853300 11000 1864300 31.65% 1853300 11000 1864300 31.65% -
e) Banks / FI - - - - - - - - -
f) Any other - - - - - - - - -
Total shareholding of Promoter (A) 2494800 148900 2643700 44.88% 2626800 16900 2643700 44.88% -
B. Public
Shareholding
1. Institutions - - - - - - - - -
a) Mutual Funds - - - - - - - - -
b) Banks / FI - - - - - - - - -
c) Central Govt - - - - - - - - -
d) State Govt(s) - - - - - - - - -
e)Venture - - - - - - - - -
Capital Funds
f) Insurance - - - - - - - - -
Companies
g) FIIs - - - - - - - - -
h) Foreign
Venture Capital - - - - - - - - -
Funds
i) Others (specify) - - - - - - - - -
Sub-total (B)(1):-

-

-

-

-

-

-

-

-

-

2. Non-Institutions
a) Bodies Corp. 65882 55400 121282 2.06% 72487 55400 127887 2.17% 1.01%
i) Indian - - - - - - - - -
ii) Overseas - - - - - - - - -
b) Individuals - - - - - - - - -
i) Individual shareholders holding nominal share capital upto Rs. 1 lakh 466865 2317800 2784665 47.28% 497718 2333000 2830718 48.06 0.78%
ii) Individual shareholders holding nominal share capital in excess of Rs 1 lakh 104427 141700 246127 4.18% 88787 101700 190487 3.23% 1.05%
c) Others (specify) 9926 84300 94226 1.60% 12908 84300 97208 1.65% 0.05%
Non Resident
Indians Overseas 9275 84300 93575 1.58% 8900 84300 93200 1.58% -
Corporate Bodies - - - - - - - - -
Foreign Nationals - - - - - - - - -
Clearing Members 651 - 651 0.01% 4008 - 4008 0.07 0.06
Trusts - - - - - - - - -
Foreign Bodies - D R - - - - - - - - -
Sub-total (B)(2):- 647100 2599200 3246300 55.12% 671900 2574400 3246300 55.12 -
Total Public
Shareholding 647100 2599200 3246300 55.12% 671900 2574400 3246300 55.12 -
(B)=(B)(1)+ (B)(2)
C. Shares held by
Custodian for GDRs & ADRs - - - - - - - - -
Grand Total (A+B+C) 3141900 2748100 5890000 100% 3298700 2591300 5890000 100% -

Shareholding of Promoter-

SN Shareholder’s Name

Shareholding at the beginning of the year

Shareholding at the end of the year

% change in shareholding during the year
No. of Shares % of total Shares of the company %of Shares Pledged / encumbered to total shares No. of Shares % of total Shares of the company %of Shares Pledged / encumbered to total shares
1 Prakash Bhoorchand Shah 760400 12.91 0 760400 12.91 0 0%
2 Rapport Investment & Trading Co Pvt Ltd. 917300 15.57 0 917300 15.57 0 0%
3 Gulechha Investment & Trading Co Pvt Ltd. 362200 6.15 0 362200 6.15 0 0%
4 Khem-Sum Apparels Overseas Ltd.

413800

7.03

0

413800

7.03

0

0%

5 Sanmitra Commercial Ltd. 140000 2.38 0 140000 2.38 0 0%
6 Gulechha Investment & Trdading Co Pvt Ltd. 10800 0.18 0 10800 0.18 0 0%
7 New Markets Advisory Ltd. 20000 0.34 0 20000 0.34 0 0%
8 Khem-Sum Apparels Overseas Ltd. 200 0.00 0 200 0.00 0 0%
9 Gulab Bhoorchand Shah 8500 0.14 0 8500 0.14 0 0%
10 Dr L L Hingorani 5000 0.08 0 5000 0.08 0 0%
11 Prakash Shah HUF 1000 0.02 0 1000 0.02 0 0%
12 Ramesh Bhoorchand Shah 1000 0.02 0 1000 0.02 0 0%
13 Suman Prakash Shah 900 0.02 0 900 0.02 0 0%
14 Shantilal Bhoorchand Shah 900 0.02 0 900 0.02 0 0%
15 Shakuntala Suresh Shah

900

0.02

0

900

0.02

0

0%

16 Leela Sudhir Bhandari 800 0.01 0 800 0.01 0 0%

C) Change in Promoters’ Shareholding:

SN Particulars Shareholding at the beginning of the year Cumulative Shareholding during the year
No. of % of total shares shares of the company No. of % of total shares shares of the company

 

1 At the beginning of the year No changes during the year
2 Changes during the year No changes during the year
3 At the end of the year No changes during the year

D) Shareholding Pattern of top ten Shareholders:

(Other than Directors Promoters and Holders of GDRs and ADRs):

SN For Each of the Top 10 Shareholders Shareholding at the beginning of the year (AS ON 01.04.2014) Cumulative Shareholding during the year (FROM 01.04.2014 TO 31.03.2015)
No. of shares % of total shares of the company No. of shares % of total shares of the company
1 VORA CONSTRUCTIONS LTD
At the beginning of the year 50168 0.8517
Changes during the Year
DATE REASON
15.04.2015 SALE 26746 0.4540
At the end of the year 23422 0.3977
2 BHAVIN R SHAH
At the beginning of the year 29300 0.4975
Changes during the Year No changes during the year
At the end of the year

29300

0.4975

3 DEVANG K MEHTA
At the beginning of the year 26400 0.4482
Changes during the Year No changes during the year
At the end of the year 26400 0.4482
4 KISAN GOPAL MUTHA
At the beginning of the year 25400 0.4482
Changes during the Year No changes during the year
At the end of the year 25400 0.4482
5 INDUJA TRADERS PVT LTD
At the beginning of the year 22400 0.3803
Changes during the Year No changes during the year
At the end of the year 22400 0.3803
6 KAUSHIK SHAH *
At the beginning of the year 20000 0.3396
Changes during the Year
DATE REASON
15.04.2015 SALE 20000 0.3396
At the end of the year Nil Nil
7 SUBASH JAIN *
At the beginning of the year 20000 0.3396
Changes during the Year
DATE REASON
15.04.2015 SALE 20000 0.3396
At the end of the year

Nil

Nil

8 PREMLATA P BOHRA
At the beginning of the year 20000 0.3396
Changes during the Year No changes during the year
At the end of the year 20000 0.3396
9 SHIV KUMAR THIRANI
At the beginning of the year 18900 0.3209
Changes during the Year No changes during the year
At the end of the year 18900 0.3209
10 ARASMAL BANSILAL KARNAWAT
At the beginning of the year 16200 0.2750
Changes during the Year No changes during the year
At the end of the year 16200 0.2750
11 VENTRUA SECURITIES LIMITED **
At the beginning of the year - -
Changes during the Year
DATE REASON
15.04.2015 BUY 28709 0.4874
At the end of the year 28709 0.4874
12 AJAY GUPTA
At the beginning of the year 15762 0.2676
Changes during the Year
DATE REASON
15.04.2015 BUY 25 0.0004
At the end of the year 15787 0.2680

*Ceased to be in the list of Top 10 Shareholders as on 31st March 2015. The same hasbeen reflected above since the shareholders were one of the Top 10 Shareholders as on 1stApril 2014.

**Not in the list of Top 10 Shareholders as on 1st April 2014. The same has beenreflected above since the shareholders were one of the Top 10 Shareholders as on 31stMarch 2015.

E) Shareholding of Directors and Key Managerial Personnel:

SN Shareholding of each Directors and each Key Managerial Personnel Shareholding at the beginning of the year Cumulative Shareholding during the year
No. of shares % of total shares of the company No. of shares % of total shares of the company
1 Prakash Shah
Executive Director
At the beginning of the year 760400 12.91% 760400 12.91%
Changes during the year

No changes during the year

At the end of the year 760400 12.91% 760400 12.91%

Shareholding of all other Directors and Key Managerial Personnel: NIL

V) INDEBTEDNESS -Indebtedness of the Company including interestoutstanding/accrued but not due for payment: NIL

VI. REMUNERATION OF DIRECTORS AND KEY MANAGERIAL PERSONNEL-

A. Remuneration to Managing Director Whole-time Directors and/or Manager:

SN. Particulars of Remuneration Key Managerial Personnel Total Amount
Man Mohan Ghildyal
Manager
1 Gross salary 180000 180000
(a) Salary as per provisions contained in section 17(1) of the Income-tax Act 1961 - -
(b) Value of perquisites u/s 17(2) Income-tax Act 1961 - -
(c) Profits in lieu of salary under section 17(3) - -
Income- tax Act 1961
2 Stock Option - -
3 Sweat Equity - -
4 Commission- as % of profit - -
- others specify…
5 Others please specify - -
Total (A) - -
Ceiling as per the Act - -

B. Remuneration to other directors: NIL

C. REMUNERATION TO KEY MANAGERIAL PERSONNEL OTHER THAN MD/MANAGER/WTD: NIL

VII. PENALTIES / PUNISHMENT/ COMPOUNDING OF OFFENCES: NIL

Upgrade To Premium Services

Welcome User

Business Standard is happy to inform you of the launch of "Business Standard Premium Services"

As a premium subscriber you get an across device unfettered access to a range of services which include:

  • Access Exclusive content - articles, features & opinion pieces
  • Weekly Industry/Genre specific newsletters - Choose multiple industries/genres
  • Access to 17 plus years of content archives
  • Set Stock price alerts for your portfolio and watch list and get them delivered to your e-mail box
  • End of day news alerts on 5 companies (via email)
  • NEW: Get seamless access to WSJ.com at a great price. No additional sign-up required.
 

Premium Services

In Partnership with

 

Dear Guest,

 

Welcome to the premium services of Business Standard brought to you courtesy FIS.
Kindly visit the Manage my subscription page to discover the benefits of this programme.

Enjoy Reading!
Team Business Standard